Ultima-Ultrazompic 5 mg

Ultrazompic 5mg/pen by Ultima Pharmaceuticals – High-Strength GLP-1 RA for Fat Loss & Metabolic Health

Now available at 7steroids.com, Ultrazompic 5mg/pen by Ultima Pharmaceuticals features Semaglutide, a next-generation GLP-1 receptor agonist (GLP-1 RA) used to reduce appetite, regulate blood sugar, and promote long-term fat loss. This high-dose, pre-filled pen format delivers convenient weekly dosing ideal for users with established tolerance or advanced weight loss needs.

Used in extended 8–20 week fat loss plans, Ultrazompic supports caloric control, decreases hunger, and improves insulin sensitivity, making it a powerful aid in body recomposition or lifestyle transformation.

Often stacked with MK-677 for muscle preservation or Tirzepatide for enhanced dual-pathway metabolic support.

Men's & Women's dosage:

Start at 0.25–0.5mg/week and gradually titrate to 2.5–5mg/week based on tolerance and results (subcutaneous, via pre-measured pen)

Ultrazompic 5mg is ideal for users ready for clinical-level fat loss, sustained craving control, and a complete metabolic shift without stimulants or hormonal disruption.